GRIMES & COMPANY, INC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
GRIMES & COMPANY, INC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$385,691
-9.5%
40,0510.0%0.02%0.0%
Q2 2023$426,143
+1.1%
40,0510.0%0.02%
-11.8%
Q1 2023$421,337
-28.9%
40,051
-16.3%
0.02%
-32.0%
Q4 2022$592,812
+19.5%
47,8460.0%0.02%
-3.8%
Q3 2022$496,000
-7.8%
47,846
+2.5%
0.03%
-3.7%
Q2 2022$538,000
-19.0%
46,691
-11.6%
0.03%
-22.9%
Q1 2022$664,000
+18.4%
52,816
+9.7%
0.04%
+34.6%
Q4 2021$561,000
-10.7%
48,132
+0.0%
0.03%
-3.7%
Q3 2021$628,000
+7.9%
48,120
+6.5%
0.03%
+8.0%
Q2 2021$582,000
+28.5%
45,198
+11.6%
0.02%
+13.6%
Q1 2021$453,000
+183.1%
40,501
+189.1%
0.02%
+175.0%
Q4 2020$160,000
+27.0%
14,0070.0%0.01%0.0%
Q3 2020$126,000
+7.7%
14,007
+23.0%
0.01%0.0%
Q2 2020$117,000
-32.4%
11,385
-33.4%
0.01%
-50.0%
Q1 2020$173,000
-24.1%
17,1000.0%0.02%
+6.7%
Q4 2019$228,000
+55.1%
17,1000.0%0.02%
+50.0%
Q3 2019$147,00017,1000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders